Cargando…

Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation

Ischemic cerebral infarction represents a significant cause of disability and death worldwide. Caspase-1 is activated by the NLRP3/ASC pathway and inflammasomes, thus triggering pyroptosis, a programmed cell death. In particular, this death is mediated by gasdermin D (GSDMD), which induces secretion...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yubin, Song, Pingping, Chen, Wei, Xie, Xuemin, Luo, Rixin, Su, Jiehua, Zhu, Yunhui, Xu, Jiamin, Liu, Rongrong, Zhu, Peizhi, Zhang, Yusheng, Huang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874210/
https://www.ncbi.nlm.nih.gov/pubmed/33584203
http://dx.doi.org/10.3389/fncel.2020.540669
_version_ 1783649545538764800
author Liang, Yubin
Song, Pingping
Chen, Wei
Xie, Xuemin
Luo, Rixin
Su, Jiehua
Zhu, Yunhui
Xu, Jiamin
Liu, Rongrong
Zhu, Peizhi
Zhang, Yusheng
Huang, Min
author_facet Liang, Yubin
Song, Pingping
Chen, Wei
Xie, Xuemin
Luo, Rixin
Su, Jiehua
Zhu, Yunhui
Xu, Jiamin
Liu, Rongrong
Zhu, Peizhi
Zhang, Yusheng
Huang, Min
author_sort Liang, Yubin
collection PubMed
description Ischemic cerebral infarction represents a significant cause of disability and death worldwide. Caspase-1 is activated by the NLRP3/ASC pathway and inflammasomes, thus triggering pyroptosis, a programmed cell death. In particular, this death is mediated by gasdermin D (GSDMD), which induces secretion of interleukin (IL)-1β and IL-18. Accordingly, inhibition of caspase-1 prevents the development and worsening of multiple neurodegenerative diseases. However, it is not clear whether inhibition of caspase-1 can preserve blood-brain barrier (BBB) integrity following cerebral infarction. This study therefore aimed at understanding the effect of caspase-1 on BBB dysfunction and its underlying mechanisms in permanent middle cerebral artery occlusion (MCAO). Our findings in rat models revealed that expression of caspase-1 was upregulated following MCAO-induced injury in rats. Consequently, pharmacologic inhibition of caspase-1 using vx-765 ameliorated ischemia-induced infarction, neurological deficits, and neuronal injury. Furthermore, inhibition of caspase-1 enhanced the encapsulation rate of pericytes at the ischemic edge, decreased leakage of both Evans Blue (EB) and matrix metalloproteinase (MMP) proteins, and upregulated the levels of tight junctions (TJs) and tissue inhibitors of metalloproteinases (TIMPs) in MCAO-injured rats. This in turn improved the permeability of the BBB. Meanwhile, vx-765 blocked the activation of ischemia-induced pyroptosis and reduced the expression level of inflammatory factors such as caspase-1, NLRP3, ASC, GSDMD, IL-1β, and IL-18. Similarly, vx-765 treatment significantly reduced the expression levels of inflammation-related receptor for advanced glycation end products (RAGE), high-mobility family box 1 (HMGB1), mitogen-activated protein kinase (MAPK), and nuclear factor-κB (NF-κB). Evidently, inhibition of caspase-1 significantly improves ischemia-associated BBB permeability and integrity by suppressing pyroptosis activation and the RAGE/MAPK pathway.
format Online
Article
Text
id pubmed-7874210
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78742102021-02-11 Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation Liang, Yubin Song, Pingping Chen, Wei Xie, Xuemin Luo, Rixin Su, Jiehua Zhu, Yunhui Xu, Jiamin Liu, Rongrong Zhu, Peizhi Zhang, Yusheng Huang, Min Front Cell Neurosci Cellular Neuroscience Ischemic cerebral infarction represents a significant cause of disability and death worldwide. Caspase-1 is activated by the NLRP3/ASC pathway and inflammasomes, thus triggering pyroptosis, a programmed cell death. In particular, this death is mediated by gasdermin D (GSDMD), which induces secretion of interleukin (IL)-1β and IL-18. Accordingly, inhibition of caspase-1 prevents the development and worsening of multiple neurodegenerative diseases. However, it is not clear whether inhibition of caspase-1 can preserve blood-brain barrier (BBB) integrity following cerebral infarction. This study therefore aimed at understanding the effect of caspase-1 on BBB dysfunction and its underlying mechanisms in permanent middle cerebral artery occlusion (MCAO). Our findings in rat models revealed that expression of caspase-1 was upregulated following MCAO-induced injury in rats. Consequently, pharmacologic inhibition of caspase-1 using vx-765 ameliorated ischemia-induced infarction, neurological deficits, and neuronal injury. Furthermore, inhibition of caspase-1 enhanced the encapsulation rate of pericytes at the ischemic edge, decreased leakage of both Evans Blue (EB) and matrix metalloproteinase (MMP) proteins, and upregulated the levels of tight junctions (TJs) and tissue inhibitors of metalloproteinases (TIMPs) in MCAO-injured rats. This in turn improved the permeability of the BBB. Meanwhile, vx-765 blocked the activation of ischemia-induced pyroptosis and reduced the expression level of inflammatory factors such as caspase-1, NLRP3, ASC, GSDMD, IL-1β, and IL-18. Similarly, vx-765 treatment significantly reduced the expression levels of inflammation-related receptor for advanced glycation end products (RAGE), high-mobility family box 1 (HMGB1), mitogen-activated protein kinase (MAPK), and nuclear factor-κB (NF-κB). Evidently, inhibition of caspase-1 significantly improves ischemia-associated BBB permeability and integrity by suppressing pyroptosis activation and the RAGE/MAPK pathway. Frontiers Media S.A. 2021-01-11 /pmc/articles/PMC7874210/ /pubmed/33584203 http://dx.doi.org/10.3389/fncel.2020.540669 Text en Copyright © 2021 Liang, Song, Chen, Xie, Luo, Su, Zhu, Xu, Liu, Zhu, Zhang and Huang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular Neuroscience
Liang, Yubin
Song, Pingping
Chen, Wei
Xie, Xuemin
Luo, Rixin
Su, Jiehua
Zhu, Yunhui
Xu, Jiamin
Liu, Rongrong
Zhu, Peizhi
Zhang, Yusheng
Huang, Min
Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation
title Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation
title_full Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation
title_fullStr Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation
title_full_unstemmed Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation
title_short Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation
title_sort inhibition of caspase-1 ameliorates ischemia-associated blood-brain barrier dysfunction and integrity by suppressing pyroptosis activation
topic Cellular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874210/
https://www.ncbi.nlm.nih.gov/pubmed/33584203
http://dx.doi.org/10.3389/fncel.2020.540669
work_keys_str_mv AT liangyubin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT songpingping inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT chenwei inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT xiexuemin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT luorixin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT sujiehua inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT zhuyunhui inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT xujiamin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT liurongrong inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT zhupeizhi inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT zhangyusheng inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation
AT huangmin inhibitionofcaspase1amelioratesischemiaassociatedbloodbrainbarrierdysfunctionandintegritybysuppressingpyroptosisactivation